Skip to main content

Treating cognitive deficits in multiple sclerosis: are we there yet?

Publication ,  Journal Article
Doraiswamy, PM; Rao, SM
Published in: Neurology
November 9, 2004

Duke Scholars

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

November 9, 2004

Volume

63

Issue

9

Start / End Page

1552 / 1553

Location

United States

Related Subject Headings

  • Piperidines
  • Nootropic Agents
  • Neurology & Neurosurgery
  • Multiple Sclerosis
  • Memory
  • Indans
  • Humans
  • Donepezil
  • Cognition Disorders
  • Cholinesterase Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Doraiswamy, P. M., & Rao, S. M. (2004). Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology, 63(9), 1552–1553. https://doi.org/10.1212/01.wnl.0000146628.30692.15
Doraiswamy, P Murali, and Stephen M. Rao. “Treating cognitive deficits in multiple sclerosis: are we there yet?Neurology 63, no. 9 (November 9, 2004): 1552–53. https://doi.org/10.1212/01.wnl.0000146628.30692.15.
Doraiswamy PM, Rao SM. Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology. 2004 Nov 9;63(9):1552–3.
Doraiswamy, P. Murali, and Stephen M. Rao. “Treating cognitive deficits in multiple sclerosis: are we there yet?Neurology, vol. 63, no. 9, Nov. 2004, pp. 1552–53. Pubmed, doi:10.1212/01.wnl.0000146628.30692.15.
Doraiswamy PM, Rao SM. Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology. 2004 Nov 9;63(9):1552–1553.

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

November 9, 2004

Volume

63

Issue

9

Start / End Page

1552 / 1553

Location

United States

Related Subject Headings

  • Piperidines
  • Nootropic Agents
  • Neurology & Neurosurgery
  • Multiple Sclerosis
  • Memory
  • Indans
  • Humans
  • Donepezil
  • Cognition Disorders
  • Cholinesterase Inhibitors